TargetMol

Nirmatrelvir

Product Code:
 
TAR-T9351
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T9351-2mg2mg£131.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9351-5mg5mg£170.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9351-1mL1 mL * 10 mM (in DMSO)£180.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9351-10mg10mg£229.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9351-25mg25mg£351.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9351-50mg50mg£503.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9351-100mg100mg£630.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9351-200mg200mg£870.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9351-500mg500mg£1,267.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
PF-07321332 is a potent and orally active inhibitor of SARS-CoV 3C-like protease (3CLPRO) .
CAS:
2628280-40-8
Formula:
C23H32F3N5O4
Molecular Weight:
499.53
Pathway:
Microbiology/Virology
Purity:
0.98
SMILES:
CC(C)(C)[C@@H](C(N(C[C@@H]1C(C)(C)[C@H]11)[C@@H]1C(N[C@@H](C[C@H](CCN1)C1=O)C#N)=O)=O)NC(C(F)(F)F)=O
Target:
SARS-CoV

References

Schooley R T , Carlin A F , Beadle J R , et al. Rethinking Remdesivir: Synthesis of Lipid Prodrugs that Substantially Enhance Anti-Coronavirus Activity. 2020. Yan H, Zhang R, Yan G, et al. Production of a versatile SARS?CoV?2 main protease biosensor based on a dimerization?dependent red fluorescent protein. Journal of Medical Virology. 2022 Yan H, Liu Z, Yan G, et al. A robust high-throughput fluorescence polarization assay for rapid screening of SARS-CoV-2 papain-like protease inhibitors. Virology. 2022 Yan H, Zhang R, Yan G, et al.Validation of baicalein and oridonin as nonspecific SARS?CoV?2 main protease inhibitors.Phytotherapy Research.2023 Wang Z, Pan Q, Ma L, et al.Anthracyclines inhibit SARS-CoV-2 infection.bioRxiv.2023: 2023.01. 10.523518.